BlackRock, Inc. 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Harpoon Therapeutics, Inc. HARP |
BlackRock Inc. BLK |
94,048 2.800% |
-77,386 (-45.14%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
BlackRock Inc. BLK |
171,433 5.200% |
31,903 (+22.86%) |
Filing |
| 2021-02-10 3:04 pm Purchase |
2021-01-31 | 13G | Harpoon Therapeutics, Inc. HARP |
BlackRock Inc. BLK |
139,531 4.400% |
3,109 (+2.28%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
BlackRock Inc. BLK |
136,421 5.400% |
136,421 (New Position) |
Filing |